WO2013040242A3 - Dermal filler compositions for fine line treatment - Google Patents
Dermal filler compositions for fine line treatment Download PDFInfo
- Publication number
- WO2013040242A3 WO2013040242A3 PCT/US2012/055211 US2012055211W WO2013040242A3 WO 2013040242 A3 WO2013040242 A3 WO 2013040242A3 US 2012055211 W US2012055211 W US 2012055211W WO 2013040242 A3 WO2013040242 A3 WO 2013040242A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dermal filler
- filler compositions
- fine line
- line treatment
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/505—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014113663A RU2626513C2 (en) | 2011-09-14 | 2012-09-13 | Dermal filler composition for small wrinkles treating |
KR1020227001920A KR20220013588A (en) | 2011-09-14 | 2012-09-13 | Dermal filler compositions for fine line treatment |
KR1020207027527A KR20200116168A (en) | 2011-09-14 | 2012-09-13 | Dermal filler compositions for fine line treatment |
AU2012308503A AU2012308503B2 (en) | 2011-09-14 | 2012-09-13 | Dermal filler compositions for fine line treatment |
JP2014530798A JP6125509B2 (en) | 2011-09-14 | 2012-09-13 | Dermal filler composition comprising an antioxidant |
EP12769798.5A EP2755630A2 (en) | 2011-09-14 | 2012-09-13 | Dermal filler compositions for fine line treatment |
KR1020147009782A KR102161861B1 (en) | 2011-09-14 | 2012-09-13 | Dermal filler compositions for fine line treatment |
KR1020217032224A KR20210125119A (en) | 2011-09-14 | 2012-09-13 | Dermal filler compositions for fine line treatment |
CA2848833A CA2848833C (en) | 2011-09-14 | 2012-09-13 | Ascorbate modified crosslinked hyaluronic acid dermal filler compositions that exhibit reduced tyndall effect |
CN201280055657.7A CN104105474B (en) | 2011-09-14 | 2012-09-13 | Dermal augmentation agent composition for microgroove treatment |
HK14111615.6A HK1198124A1 (en) | 2011-09-14 | 2014-11-17 | Dermal filler compositions for fine line treatment |
AU2015255254A AU2015255254B2 (en) | 2011-09-14 | 2015-11-12 | Dermal filler compositions for fine line treatment |
AU2017236004A AU2017236004A1 (en) | 2011-09-14 | 2017-09-29 | Dermal filler compositions for fine line treatment |
AU2019203660A AU2019203660B2 (en) | 2011-09-14 | 2019-05-24 | Dermal filler compositions for fine line treatment |
AU2021200516A AU2021200516B2 (en) | 2011-09-14 | 2021-01-28 | Dermal filler compositions for fine line treatment |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161534780P | 2011-09-14 | 2011-09-14 | |
US61/534,780 | 2011-09-14 | ||
PCT/US2012/052125 WO2013028904A2 (en) | 2011-08-25 | 2012-08-23 | Dermal filler compositions including antioxidants |
USPCT/US2012/052125 | 2012-08-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013040242A2 WO2013040242A2 (en) | 2013-03-21 |
WO2013040242A3 true WO2013040242A3 (en) | 2014-03-13 |
Family
ID=47883970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/055211 WO2013040242A2 (en) | 2011-09-14 | 2012-09-13 | Dermal filler compositions for fine line treatment |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2755630A2 (en) |
JP (4) | JP6125509B2 (en) |
KR (4) | KR20220013588A (en) |
CN (2) | CN108379112A (en) |
AU (1) | AU2012308503B2 (en) |
CA (1) | CA2848833C (en) |
HK (1) | HK1198124A1 (en) |
RU (1) | RU2626513C2 (en) |
WO (1) | WO2013040242A2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2861734B1 (en) | 2003-04-10 | 2006-04-14 | Corneal Ind | CROSSLINKING OF LOW AND HIGH MOLECULAR MASS POLYSACCHARIDES; PREPARATION OF INJECTABLE SINGLE PHASE HYDROGELS; POLYSACCHARIDES AND HYDROGELS OBTAINED |
EP2484387A1 (en) | 2011-02-03 | 2012-08-08 | Q-Med AB | Hyaluronic acid composition |
CN103702659B (en) | 2011-06-03 | 2016-12-21 | 阿勒根公司 | Dermal filler composition including antioxidant |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
EP2755630A2 (en) * | 2011-09-14 | 2014-07-23 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
KR102168028B1 (en) * | 2011-12-08 | 2020-10-20 | 알러간 인더스트리 에스에이에스 | Dermal filler compositions |
US20140315828A1 (en) * | 2013-04-22 | 2014-10-23 | Allergan, Inc. | Cross-linked silk-hyaluronic acid compositions |
WO2014172784A1 (en) * | 2013-04-25 | 2014-10-30 | Aluron Biopharma Inc. | Crosslinked hyaluronic acid compositions |
WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
EP3653232A1 (en) * | 2015-02-13 | 2020-05-20 | Allergan Industrie, SAS | Implants for sculpting, augmenting or correcting facial features such as the chin |
US10988600B2 (en) * | 2016-06-23 | 2021-04-27 | Galderma Holding SA | Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof |
EP3503841A4 (en) | 2016-08-24 | 2020-04-22 | Allergan, Inc. | Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation |
US11389563B2 (en) | 2017-06-12 | 2022-07-19 | Advanced Aesthetic Technologies, Inc. | Dermal filler |
SG11201913229PA (en) * | 2017-06-26 | 2020-01-30 | Evolved By Nature Inc | Silk-hyaluronic acid based tissue fillers and methods of using the same |
US20230190997A1 (en) | 2017-06-26 | 2023-06-22 | Evolved By Nature, Inc. | Silk-hyaluronic acid based tissue filers and methods of using the same |
JP2020528407A (en) * | 2017-07-19 | 2020-09-24 | デンツプライ シロナ インコーポレイテッド | Water-soluble hydrogel-based dental composition and its preparation and usage |
RU2756546C1 (en) * | 2017-12-29 | 2021-10-01 | Матекс Лаб С.П.А. | Method for producing a filler based on hyaluronic acid |
KR101967153B1 (en) | 2018-04-04 | 2019-04-09 | 윤성준 | The material composition of the filler improving wrinkles, atrophic scars and other skin deficits |
CN112334167A (en) * | 2018-06-15 | 2021-02-05 | 克罗马药品有限责任公司 | Hydrogel compositions comprising crosslinked polymers |
IT201900006929A1 (en) * | 2019-05-16 | 2020-11-16 | Giuliani Spa | KIT FOR AESTHETIC SKIN TREATMENT |
CN110467689A (en) * | 2019-09-09 | 2019-11-19 | 山东众山生物科技有限公司 | A kind of derivatives of hyaluronic acids and preparation method thereof |
CN110907370A (en) * | 2019-12-04 | 2020-03-24 | 桂林理工大学 | Universal ultra-sensitive chemical and biological colorimetric sensing method |
US20230040919A1 (en) * | 2019-12-26 | 2023-02-09 | Allergan, Inc. | Crosslinked ha-collagen hydrogels as dermal fillers |
CN111249172A (en) * | 2020-01-15 | 2020-06-09 | 陈勇 | Beauty injection gel and preparation method thereof |
WO2023135135A1 (en) | 2022-01-11 | 2023-07-20 | Gpq S.R.L. | New hyaluronic acid derivatives as innovative fillers |
WO2024055132A1 (en) * | 2022-09-12 | 2024-03-21 | Universidad De Talca | Method for the synthesis of a branched copolymer of hyaluronic acid and poly(lactic-co-glycolic) acid |
KR20240096331A (en) | 2022-12-19 | 2024-06-26 | 주식회사 코루파마 | A preparing method for hydrogel combining hyaluronic acid and agar or agarose, a hydrogel comprising hyaluronic acid and agar or agarose prepared therefrom, and a filler composition comprising the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110171286A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan, Inc. | Hyaluronic acid compositions for dermatological use |
US20110171311A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6174999B1 (en) * | 1987-09-18 | 2001-01-16 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
KR100721752B1 (en) * | 2000-01-24 | 2007-05-25 | 쿠라레 메디카루 가부시키가이샤 | Water-swellable polymer gel and process for preparing the same |
IT1317091B1 (en) * | 2000-02-08 | 2003-05-26 | S F I R Societa Fondaria Ind R | CROSS-LINKED HYALURONIC ACID GEL WITH B-FUNCTIONAL L-AMINO ACIDS. |
FR2811996B1 (en) | 2000-07-19 | 2003-08-08 | Corneal Ind | CROSS-LINKING OF POLYSACCHARIDE (S), PREPARATION OF HYDROGEL (S); POLYSACCHARIDE (S) AND HYDROGEL (S) OBTAINED, THEIR USES |
WO2004067575A1 (en) * | 2003-01-31 | 2004-08-12 | Biosphere S.P.A. | Water soluble and biocompatible gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters |
AU2003206922A1 (en) | 2003-02-19 | 2004-09-09 | Aventis Pharmaceuticals Holdings Inc. | Composition and method for intradermal soft tissue augmentation |
FR2861734B1 (en) | 2003-04-10 | 2006-04-14 | Corneal Ind | CROSSLINKING OF LOW AND HIGH MOLECULAR MASS POLYSACCHARIDES; PREPARATION OF INJECTABLE SINGLE PHASE HYDROGELS; POLYSACCHARIDES AND HYDROGELS OBTAINED |
US8124120B2 (en) * | 2003-12-22 | 2012-02-28 | Anika Therapeutics, Inc. | Crosslinked hyaluronic acid compositions for tissue augmentation |
AU2004312532B2 (en) * | 2003-12-30 | 2010-05-20 | Genzyme Corporation | Cohesive gels form cross-linked hyaluronan and/or hylan, their preparation and use |
FR2865737B1 (en) * | 2004-02-03 | 2006-03-31 | Anteis Sa | BIOCOMPATIBLE RETICLE GEL |
US20050281880A1 (en) * | 2004-05-20 | 2005-12-22 | Wei Wang | Methods for making injectable polymer hydrogels |
FR2873379B1 (en) * | 2004-07-23 | 2008-05-16 | Jerome Asius | PROCESS FOR THE PREPARATION OF RETICULATED HYALURONIC ACID, RETICULATED HYALURONIC ACID WHICH CAN BE OBTAINED BY THIS METHOD, IMPLANT CONTAINING THE RETICULATED HYALURONIC ACID, AND USE THEREOF |
FR2878444B1 (en) | 2004-11-30 | 2008-04-25 | Corneal Ind Soc Par Actions Si | VISCOELASTIC SOLUTIONS COMPRISING SODIUM HYALURONATE AND HYDROXYPROPYLMETHYLCELLULOSE, PREPARATION AND USES |
KR20080067619A (en) * | 2005-09-15 | 2008-07-21 | 유니버시티 오브 유타 리써치 파운데이션 | Polymeric compositions and methods of making and using thereof |
WO2007101243A1 (en) * | 2006-02-28 | 2007-09-07 | Novozymes Biopolymer A/S | Derivatives of hyaluronic acids |
CN1837265A (en) * | 2006-04-25 | 2006-09-27 | 江南大学 | Process for composite modification of hyaluronic acid and carboxymethyl cellulose |
CN100417666C (en) * | 2006-09-07 | 2008-09-10 | 重庆大学 | Lysine-chitosan resin and preparation method thereof |
FR2908415B1 (en) * | 2006-11-10 | 2009-01-23 | Abr Dev Sarl | RETICULATED HYALURONIC ACID AND PROCESS FOR PREPARING THE SAME |
FR2909560B1 (en) * | 2006-12-06 | 2012-12-28 | Fabre Pierre Dermo Cosmetique | HYALURONIC ACID GEL FOR INTRADERMAL INJECTION |
FR2918377B1 (en) * | 2007-07-05 | 2010-10-08 | Estelle Piron | CO-RETICLE GEL OF POLYSACCHARIDES |
US8394782B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
EP2219679A1 (en) * | 2007-12-21 | 2010-08-25 | Encecor AB | Cross-linked hydrogel containing an active substance |
KR20090110090A (en) * | 2008-04-17 | 2009-10-21 | 엘지전자 주식회사 | Synthesis method for indium selenide nanoparticles by ultrasonic waves and a compound semiconductor solar cell comprising the said |
US8450475B2 (en) | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
CN101961344A (en) * | 2009-07-23 | 2011-02-02 | 山东省生物药物研究院 | Drug composite and application thereof |
IT1395392B1 (en) * | 2009-08-27 | 2012-09-14 | Fidia Farmaceutici | VISCOELASTIC FROSTS LIKE NEW FILLERS |
EP3037102A1 (en) * | 2009-11-23 | 2016-06-29 | Stephen F. Olmstead | Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
US20110172180A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
CN103702659B (en) * | 2011-06-03 | 2016-12-21 | 阿勒根公司 | Dermal filler composition including antioxidant |
EP2755630A2 (en) * | 2011-09-14 | 2014-07-23 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
-
2012
- 2012-09-13 EP EP12769798.5A patent/EP2755630A2/en not_active Withdrawn
- 2012-09-13 WO PCT/US2012/055211 patent/WO2013040242A2/en unknown
- 2012-09-13 RU RU2014113663A patent/RU2626513C2/en active
- 2012-09-13 KR KR1020227001920A patent/KR20220013588A/en active Application Filing
- 2012-09-13 AU AU2012308503A patent/AU2012308503B2/en active Active
- 2012-09-13 CN CN201810249654.6A patent/CN108379112A/en active Pending
- 2012-09-13 KR KR1020217032224A patent/KR20210125119A/en active IP Right Grant
- 2012-09-13 CA CA2848833A patent/CA2848833C/en active Active
- 2012-09-13 JP JP2014530798A patent/JP6125509B2/en active Active
- 2012-09-13 CN CN201280055657.7A patent/CN104105474B/en active Active
- 2012-09-13 KR KR1020147009782A patent/KR102161861B1/en active IP Right Grant
- 2012-09-13 KR KR1020207027527A patent/KR20200116168A/en not_active Application Discontinuation
-
2014
- 2014-11-17 HK HK14111615.6A patent/HK1198124A1/en unknown
-
2017
- 2017-04-05 JP JP2017075224A patent/JP2017140433A/en not_active Withdrawn
-
2018
- 2018-11-22 JP JP2018219395A patent/JP2019058692A/en not_active Withdrawn
-
2021
- 2021-03-23 JP JP2021048584A patent/JP2021100603A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110171286A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan, Inc. | Hyaluronic acid compositions for dermatological use |
US20110171311A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
Non-Patent Citations (1)
Title |
---|
PARK DJ ET AL: "IN VITRO EVALUATION OF CONJUGATED HYALURONIC ACID WITH ASCORBIC ACID", JOURNAL OF BONE AND JOINT SURGERY,, vol. 92-B, no. SUPP I, 1 January 2010 (2010-01-01), pages 115, XP002706399 * |
Also Published As
Publication number | Publication date |
---|---|
KR20220013588A (en) | 2022-02-04 |
CN104105474A (en) | 2014-10-15 |
KR20210125119A (en) | 2021-10-15 |
KR20200116168A (en) | 2020-10-08 |
RU2626513C2 (en) | 2017-07-28 |
WO2013040242A2 (en) | 2013-03-21 |
CA2848833C (en) | 2017-04-04 |
CA2848833A1 (en) | 2013-03-21 |
RU2014113663A (en) | 2015-10-20 |
KR102161861B1 (en) | 2020-10-26 |
AU2012308503B2 (en) | 2015-08-13 |
JP2014526342A (en) | 2014-10-06 |
CN108379112A (en) | 2018-08-10 |
JP2017140433A (en) | 2017-08-17 |
EP2755630A2 (en) | 2014-07-23 |
JP2021100603A (en) | 2021-07-08 |
CN104105474B (en) | 2018-04-06 |
JP6125509B2 (en) | 2017-05-10 |
AU2012308503A1 (en) | 2014-04-03 |
HK1198124A1 (en) | 2015-03-13 |
KR20140096028A (en) | 2014-08-04 |
JP2019058692A (en) | 2019-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013040242A3 (en) | Dermal filler compositions for fine line treatment | |
JOP20180102B1 (en) | Pharmaceutical composition | |
WO2012167079A3 (en) | Dermal filler compositions including antioxidants | |
MX2018016021A (en) | Compositions and methods comprising a lipolytic enzyme variant. | |
MX352892B (en) | Yeast-muc1 immunotherapeutic compositions and uses thereof. | |
EP2681268B8 (en) | Organosiloxane compositions | |
MX2012015188A (en) | Controlled release compositions with reduced food effect. | |
WO2013086024A3 (en) | Dermal filler compositions | |
PH12014501273A1 (en) | Intranasal dexmedetomidine compositions and methods of use thereof | |
EP2872151A4 (en) | Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases | |
MY169328A (en) | Compositions for the treatment of dry eye | |
IN2014DN08299A (en) | ||
GEP201706739B (en) | Compositions comprising vortioxetine and donepezil | |
WO2013120022A3 (en) | Treatment of hypoglycemia | |
MX359181B (en) | Collagen hydrolysate and use thereof. | |
EP4023243A3 (en) | Compositions and methods for treating celiac sprue disease | |
WO2012017321A3 (en) | Treatment for dyslipidemia | |
IN2014DN00254A (en) | ||
EP3076952A4 (en) | Composition for oral delivery of bioactive agents | |
HK1215682A1 (en) | Compositions, uses and methods for treating or preventing dental caries | |
MY165088A (en) | Pharmaceutical compositions comprising alisporivir | |
UA117567C2 (en) | Galactagogue compositions based on phosphatidylserine | |
MX2015005846A (en) | Block copolymers for tooth enamel protection. | |
WO2014022475A8 (en) | Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers | |
EP2569327A4 (en) | Eif4e binding peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12769798 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2014530798 Country of ref document: JP Kind code of ref document: A Ref document number: 2848833 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2012308503 Country of ref document: AU Date of ref document: 20120913 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20147009782 Country of ref document: KR Kind code of ref document: A Ref document number: 2014113663 Country of ref document: RU Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12769798 Country of ref document: EP Kind code of ref document: A2 |